{"id":145,"date":"2023-07-30T12:15:00","date_gmt":"2023-07-30T10:15:00","guid":{"rendered":"https:\/\/aplusa.local\/?p=145"},"modified":"2026-02-03T17:17:55","modified_gmt":"2026-02-03T16:17:55","slug":"social-media-impact-of-asco-2023","status":"publish","type":"post","link":"https:\/\/www.aplusaresearch.com\/fr\/perspectives\/social-media-impact-of-asco-2023\/","title":{"rendered":"Impact de l'ASCO 2023 sur les m\u00e9dias sociaux"},"content":{"rendered":"<p>La r\u00e9union annuelle 2023 de l'ASCO (American Society of Clinical Oncology) s'est d\u00e9roul\u00e9e du 2 au 6 juin 2023 \u00e0 Chicago, Il, \u00c9tats-Unis. Cette ann\u00e9e, l'\u00e9v\u00e9nement s'est principalement d\u00e9roul\u00e9 en personne, avec des diffusions virtuelles disponibles. Le programme en un coup d'\u0153il est disponible ici. Comme c'est le cas depuis 2019, nous \u00e9valuerons l'impact de la conf\u00e9rence en ligne :<\/p>\n\n\n\n<p>Du point de vue des HCP :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Conditions et m\u00e9dicaments les plus discut\u00e9s pendant la p\u00e9riode d'\u00e9coute<\/li>\n\n\n\n<li>Messages ayant g\u00e9n\u00e9r\u00e9 le plus d'engagement<\/li>\n\n\n\n<li>Focus sur le my\u00e9lome multiple<\/li>\n<\/ul>\n\n\n\n<p>Du point de vue des entreprises pharmaceutiques :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Principales entreprises pharmaceutiques (en termes de mentions)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Champ d'application<\/h2>\n\n\n\n<p>L'analyse porte sur les mentions provenant du monde entier*.<\/p>\n\n\n\n<p>Au total, 86K mentions ont \u00e9t\u00e9 enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute du 26 mai 2023 au 20 juin 2023 (une semaine avant et deux semaines apr\u00e8s la conf\u00e9rence).<\/p>\n\n\n\n<p>Toutes les mentions proviennent de Twitter.<\/p>\n\n\n\n<p>Au total, 13 000 auteurs uniques ont \u00e9t\u00e9 identifi\u00e9s.<\/p>\n\n\n\n<p class=\"is-style-text-annotation\">*#asco23 OR #asco2023 OR (asco NEAR\/2 (2023 OR 23))<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">M\u00e9thodologie<\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"286\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-34-27-6713-am-1024x286.avif\" class=\"wp-image-360\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-34-27-6713-am-1024x286.avif 1024w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-34-27-6713-am-300x84.avif 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-34-27-6713-am-768x215.avif 768w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-34-27-6713-am-1536x430.avif 1536w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-34-27-6713-am.avif 1873w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"is-style-text-annotation\">**#asco23 OR #asco2023 OR (asco NEAR\/2 (2023 OR 23))<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Volume des conversations<\/h2>\n\n\n\n<p>Il y a eu une l\u00e9g\u00e8re diminution des mentions globales de 1 74% par rapport \u00e0 ASCO 2022, les HCP repr\u00e9sentant la majeure partie des conversations avec 78%. Comme d'habitude, le pic des conversations a eu lieu pendant la conf\u00e9rence, repr\u00e9sentant 68% des mentions enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"389\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/promo-sml-de-habib.webp\" class=\"wp-image-361\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/promo-sml-de-habib.webp 960w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/promo-sml-de-habib-300x122.webp 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/promo-sml-de-habib-768x311.webp 768w\" sizes=\"auto, (max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Top posts (de HCP)<\/h2>\n\n\n\n<p>Le plus appr\u00e9ci\u00e9 : ce tweet fait r\u00e9f\u00e9rence \u00e0 la p\u00e9nurie de m\u00e9dicaments exp\u00e9riment\u00e9s dans le domaine des chimioth\u00e9rapies. Un point soulign\u00e9 \u00e0 l'origine par notre coll\u00e8gue Dr Maura Barry.<\/p>\n\n\n\n<p>Le plus retweet\u00e9 : Ce post met en avant le r\u00e9sum\u00e9 12005 qui pr\u00e9sente le diclof\u00e9nac topique comme pr\u00e9venant le syndrome main-pied chez les patients recevant de la capecitabine.<\/p>\n\n\n\n<p>Le plus grand nombre de r\u00e9ponses : Les messages qui ont re\u00e7u le plus de commentaires \u00e9taient des messages de f\u00e9licitations \u00e0 l'\u00e9gard du Dr LoComte qui a re\u00e7u le titre de FASCO.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"620\" height=\"409\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/promo-sml-de-habib-1.webp\" class=\"wp-image-362\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/promo-sml-de-habib-1.webp 620w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/promo-sml-de-habib-1-300x198.webp 300w\" sizes=\"auto, (max-width: 620px) 100vw, 620px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Top hashtags<\/h2>\n\n\n\n<p>Le hashtag le plus utilis\u00e9 \u00e9tait #lcsm (m\u00e9dias sociaux sur le cancer du poumon).<\/p>\n\n\n\n<p>Cette liste correspond aux maladies les plus discut\u00e9es lors de la conf\u00e9rence, \u00e0 savoir les cancers du poumon et du sein, ainsi que le cancer de la prostate.<br>my\u00e9lome multiple.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"433\" height=\"437\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-45-24-5705-am.webp\" class=\"wp-image-363\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-45-24-5705-am.webp 433w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-45-24-5705-am-297x300.webp 297w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-45-24-5705-am-150x150.webp 150w\" sizes=\"auto, (max-width: 433px) 100vw, 433px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">SOV Produit et type de cancer parmi les professionnels de la sant\u00e9<\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"460\" height=\"411\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-48-39-4372-am.webp\" class=\"wp-image-365\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-48-39-4372-am.webp 460w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-48-39-4372-am-300x268.webp 300w\" sizes=\"auto, (max-width: 460px) 100vw, 460px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"450\" height=\"404\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-49-09-1040-am.webp\" class=\"wp-image-366\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-49-09-1040-am.webp 450w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-08-49-09-1040-am-300x269.webp 300w\" sizes=\"auto, (max-width: 450px) 100vw, 450px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p class=\"is-style-text-annotation\">Note : cancer de l'estomac, carcinome de primitif inconnu, cancer de la t\u00eate et du cou, cancer de l'\u0153sophage, cancer des voies biliaires, cancer de la peau, cancer du thymus, cancer du sang \u00e0 moins de 1%.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">KEYTRUDA (pembrolizumab)<\/h3>\n\n\n\n<p>Le Keynote 671 \u00e9tait particuli\u00e8rement int\u00e9ressant pour les professionnels de la sant\u00e9, car il montrait une am\u00e9lioration de la survie sans \u00e9v\u00e9nement ainsi qu'une r\u00e9duction du risque de r\u00e9currence, de progression ou de d\u00e9c\u00e8s de la maladie gr\u00e2ce au 42% dans les cancers du poumon non \u00e0 petites cellules r\u00e9s\u00e9cables de stade II, IIIA ou IIIB.<\/p>\n\n\n\n<p>Type de cancer mentionn\u00e9 :<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"347\" height=\"128\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-19-42-1300-am.webp\" class=\"wp-image-367\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-19-42-1300-am.webp 347w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-19-42-1300-am-300x111.webp 300w\" sizes=\"auto, (max-width: 347px) 100vw, 347px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"606\" height=\"390\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-23-39-1784-am.webp\" class=\"wp-image-368\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-23-39-1784-am.webp 606w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-23-39-1784-am-300x193.webp 300w\" sizes=\"auto, (max-width: 606px) 100vw, 606px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\">OPDIVO (nivolumab)<\/h3>\n\n\n\n<p>Plusieurs r\u00e9sultats d'essais cliniques sur le cancer RCC ont \u00e9t\u00e9 pr\u00e9sent\u00e9s. Il convient de noter l'essai checkmate 914, qui fait \u00e9tat d'analyses de sous-groupes b\u00e9n\u00e9ficiant \u00e0 certains patients atteints d'un cancer du c\u00f4lon irritable. D'autres essais cliniques ont \u00e9t\u00e9 mentionn\u00e9s, notamment checkmate 214 et checkmate 9ER.<\/p>\n\n\n\n<p>Type de cancer mentionn\u00e9 :<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"339\" height=\"106\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-30-09-5810-am.webp\" class=\"wp-image-369\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-30-09-5810-am.webp 339w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-30-09-5810-am-300x94.webp 300w\" sizes=\"auto, (max-width: 339px) 100vw, 339px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"619\" height=\"399\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-26-47-0745-am.webp\" class=\"wp-image-370\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-26-47-0745-am.webp 619w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-26-47-0745-am-300x193.webp 300w\" sizes=\"auto, (max-width: 619px) 100vw, 619px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\">TAGRISSO (osimertinib)<\/h3>\n\n\n\n<p>Les principales nouvelles concernant TAGRISSO proviennent de l'\u00e9tude ADAURA qui a montr\u00e9 une am\u00e9lioration de la survie chez les patients atteints d'un cancer du poumon non \u00e0 petites cellules (CPNPC) mut\u00e9 par le R-EGF. Les r\u00e9sultats ont \u00e9t\u00e9 jug\u00e9s r\u00e9volutionnaires, impressionnants et renfor\u00e7ant l'osimertinib adjuvant comme norme de soins pour les patients atteints de CPNPC EGFR mut\u00e9 de stade IB \u00e0 IIIA.<\/p>\n\n\n\n<p>Type de cancer mentionn\u00e9 :<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"336\" height=\"72\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-28-12-8424-am.webp\" class=\"wp-image-371\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-28-12-8424-am.webp 336w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-28-12-8424-am-300x64.webp 300w\" sizes=\"auto, (max-width: 336px) 100vw, 336px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"621\" height=\"402\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-31-14-1584-am.webp\" class=\"wp-image-372\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-31-14-1584-am.webp 621w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-31-14-1584-am-300x194.webp 300w\" sizes=\"auto, (max-width: 621px) 100vw, 621px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\">Focus sur le my\u00e9lome multiple<\/h2>\n\n\n\n<p>L'\u00e9dition de cette ann\u00e9e \u00e9tait fortement ax\u00e9e sur les th\u00e9rapies cellulaires CAR-T et les anticorps bisp\u00e9cifiques.<\/p>\n\n\n\n<p>Les r\u00e9sultats tr\u00e8s attendus de l'essai CARTITUDE-4 en t\u00e9moignent. D'autres d\u00e9veloppements \u00e0 noter sont le teclistamab et le talquetamab et les essais correspondants RedirecTT-1 et MajesTEC-1.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sujets de discussion (type de traitement)<\/h3>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"495\" height=\"211\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-01-41-0569-am.webp\" class=\"wp-image-373\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-01-41-0569-am.webp 495w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-01-41-0569-am-300x128.webp 300w\" sizes=\"auto, (max-width: 495px) 100vw, 495px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"461\" height=\"200\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-02-58-2083-am.webp\" class=\"wp-image-374\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-02-58-2083-am.webp 461w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-02-58-2083-am-300x130.webp 300w\" sizes=\"auto, (max-width: 461px) 100vw, 461px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Volume des mentions<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"424\" height=\"90\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-04-41-5557-am.webp\" class=\"wp-image-375\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-04-41-5557-am.webp 424w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-04-41-5557-am-300x64.webp 300w\" sizes=\"auto, (max-width: 424px) 100vw, 424px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Essais cliniques les plus mentionn\u00e9s<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"603\" height=\"265\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-06-52-6152-am.webp\" class=\"wp-image-378\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-06-52-6152-am.webp 603w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-06-52-6152-am-300x132.webp 300w\" sizes=\"auto, (max-width: 603px) 100vw, 603px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Mol\u00e9cules les plus cit\u00e9es<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"669\" height=\"204\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-32-52-8337-am.webp\" class=\"wp-image-379\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-32-52-8337-am.webp 669w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-32-52-8337-am-300x91.webp 300w\" sizes=\"auto, (max-width: 669px) 100vw, 669px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Principaux messages des professionnels de la sant\u00e9 par engagement<\/h3>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"462\" height=\"310\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-34-50-0901-am.webp\" class=\"wp-image-380\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-34-50-0901-am.webp 462w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-34-50-0901-am-300x201.webp 300w\" sizes=\"auto, (max-width: 462px) 100vw, 462px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"401\" height=\"318\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-35-53-6028-am.webp\" class=\"wp-image-381\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-35-53-6028-am.webp 401w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-10-35-53-6028-am-300x238.webp 300w\" sizes=\"auto, (max-width: 401px) 100vw, 401px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Activit\u00e9 pendant ASCO 2022 : 15 premiers comptes twitter commerciaux par volume de messages (contenu original, excluant les retweets ou les commentaires)<\/h3>\n\n\n\n<figure class=\"wp-block-image size-large\"><img alt=\"\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"520\" src=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-12-26-44-8595-pm-1024x520.avif\" class=\"wp-image-382\" srcset=\"https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-12-26-44-8595-pm-1024x520.avif 1024w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-12-26-44-8595-pm-300x152.avif 300w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-12-26-44-8595-pm-768x390.avif 768w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-12-26-44-8595-pm-1536x780.avif 1536w, https:\/\/www.aplusaresearch.com\/wp-content\/uploads\/2023\/07\/image-png-jun-30-2023-12-26-44-8595-pm.avif 1819w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Comparaison d'une ann\u00e9e sur l'autre<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Le nombre total de mentions relatives \u00e0 l'ASCO 2023 a diminu\u00e9 de seulement 1 74% par rapport \u00e0 l'\u00e9dition 2022, passant de 87k mentions \u00e0 86K mentions en 2023.<\/li>\n\n\n\n<li>Le volume des mentions provenant des HCP a l\u00e9g\u00e8rement diminu\u00e9 de 3 91% d'une ann\u00e9e sur l'autre, passant de 31 024 en 2022 \u00e0 29 812 en 2023.<\/li>\n\n\n\n<li>Le volume des mentions des entreprises pharmaceutiques a diminu\u00e9 par rapport \u00e0 l'ann\u00e9e derni\u00e8re, passant de 1458 en 2022 \u00e0 855 en 2023, soit une baisse de 41 36%.<\/li>\n\n\n\n<li>Le volume des mentions des organisations a diminu\u00e9, passant de 10604 en 2022 \u00e0 8667 en 2023, soit une baisse de 18%.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>The 2023 ASCO (American Society of Clinical Oncology) annual meeting took place from June 2nd to June 6th, 2023, in Chicago, Il, USA. This year\u2019s event was primarily an in-person event with virtual broadcasts available. The program at a glance is available here. As has been the case since 2019 we will be assessing the [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":7322,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"ASCO 2023 insights: 86K tweets analyzed on lung, breast, and multiple myeloma, top drugs, HCP engagement, and pharma share of voice.","_seopress_robots_index":"","content-type":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-145","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-views"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/comments?post=145"}],"version-history":[{"count":0,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/145\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/7322"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/categories?post=145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/tags?post=145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}